vTv Therapeutics Inc. (VTVT) P/E Ratio History
Deep ValueTrading at -11.0x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2026–2026
Loading P/E history...
P/E Ratio Analysis
As of June 28, 2026, vTv Therapeutics Inc. (VTVT) trades at a price-to-earnings ratio of -11.0x, with a stock price of $35.08 and trailing twelve-month earnings per share of $0.27.
The current P/E is 101% below its 5-year average of 1983.0x. Over the past five years, VTVT's P/E has ranged from a low of 1983.0x to a high of 1983.0x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 23.0x, VTVT trades at a 148% discount to its sector peers. The sector includes 231 companies with P/E ratios ranging from 0.0x to 191.4x.
Relative to the broader market, VTVT trades at a notable discount to the S&P 500 median P/E of 25.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our VTVT DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
VTVT Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
VTVT P/E vs Peers
Metabolic and Obesity Therapies peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $2B | 7.1Lowest | 0.69Best | +817% | |
| $6B | 49.5 | - | +2886%Best | |
| $4B | 11.1 | - | +68% | |
| $9B | 106.5 | - | -33% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
VTVT Historical P/E Data (2026–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | - | $39.66 | $0.02 | 1983.0x | +0% |
Average P/E for displayed period: 1983.0x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
10-year return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
VTVT — Frequently Asked Questions
Quick answers to the most common questions about buying VTVT stock.
What is VTVT's P/E ratio?
vTv Therapeutics Inc. (VTVT) trailing twelve-month P/E ratio is -11.0x, based on TTM diluted EPS of $0.27. The 5-year average P/E is 1983.0x and the historical range spans 1983.0x to 1983.0x.
Is VTVT stock overvalued or undervalued?
VTVT trades at -11.0x P/E, below its 5-year average of 1983.0x. At the 0th percentile of its historical range (1983.0x–1983.0x), the stock is priced at a discount to its own history.
Is VTVT stock expensive?
No, VTVT is not expensive on a historical basis. The current P/E of -11.0x is below the 5-year average of 1983.0x and sits at the 0th percentile of its valuation range.
What is VTVT's historical P/E range?
Over the past 5 years, VTVT's P/E ratio has ranged from 1983.0x to 1983.0x, with a median of 1983.0x and an average of 1983.0x. The current P/E of -11.0x places the stock at the 0th percentile of this range. Full historical data spans 2026–2026.
How does VTVT's P/E compare to the S&P 500?
VTVT trades at -11.0x P/E versus the S&P 500 median of 25.3x. The 143% discount to the market suggests lower growth expectations or perceived higher risk.
How does VTVT's valuation compare to Healthcare peers?
vTv Therapeutics Inc. P/E of -11.0x compares to the Healthcare sector median of 23.0x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is VTVT's PEG ratio?
VTVT PEG ratio is N/A, based on a P/E of -11.0x and EPS growth of 0.0%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is VTVT's earnings yield?
VTVT earnings yield is N/A, the inverse of its -11.0x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.